Physicochemical Properties
| Molecular Formula | C₂₁H₃₀CL₂N₂O₂ |
| Molecular Weight | 413.3811 |
| Exact Mass | 412.168 |
| CAS # | 13073-96-6 |
| Related CAS # | Decloxizine; 3733-63-9 |
| PubChem CID | 83104 |
| Appearance | White to off-white solid powder |
| Density | 1.115g/cm3 |
| Boiling Point | 472.4ºC at 760mmHg |
| Flash Point | 239.5ºC |
| Vapour Pressure | 9.93E-10mmHg at 25°C |
| LogP | 3.882 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Heavy Atom Count | 27 |
| Complexity | 328 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | RBSDUJACXBVDDN-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C21H28N2O2.2ClH/c24-16-18-25-17-15-22-11-13-23(14-12-22)21(19-7-3-1-4-8-19)20-9-5-2-6-10-20;;/h1-10,21,24H,11-18H2;2*1H |
| Chemical Name | 2-[2-(4-benzhydrylpiperazin-1-yl)ethoxy]ethanol;dihydrochloride |
| Synonyms | UCB-1402; NSC-289116; UCB1402; NSC289116; UCB 1402; NSC 289116 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Arch Int Pharmacodyn Ther . 1969 Nov;182(1):215-8. |
| Additional Infomation | See also: Decloxizine (annotation moved to). |
Solubility Data
| Solubility (In Vitro) |
H2O : ≥ 100 mg/mL (~241.91 mM) DMSO : ≥ 50 mg/mL (~120.95 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.05 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.05 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (6.05 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 4: 100 mg/mL (241.91 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4191 mL | 12.0954 mL | 24.1908 mL | |
| 5 mM | 0.4838 mL | 2.4191 mL | 4.8382 mL | |
| 10 mM | 0.2419 mL | 1.2095 mL | 2.4191 mL |